Recommendation mapping of the World Health Organization's guidelines on tuberculosis: A new approach to digitizing and presenting recommendations.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
06 2021
Historique:
received: 19 12 2020
revised: 27 01 2021
accepted: 04 02 2021
pubmed: 26 3 2021
medline: 30 9 2021
entrez: 25 3 2021
Statut: ppublish

Résumé

Having up-to-date health policy recommendations accessible in one location is in high demand by guideline users. We developed an easy to navigate interactive approach to organize recommendations and applied it to tuberculosis (TB) guidelines of the World Health Organization (WHO). We used a mixed-methods study design to develop a framework for recommendation mapping with seven key methodological considerations. We define a recommendation map as an online repository of recommendations from several guidelines on a condition, providing links to the underlying evidence and expert judgments that inform them, allowing users to filter and cross-tabulate the search results. We engaged guideline developers, users, and health software engineers in an iterative process to elaborate the WHO eTB recommendation map. Applying the seven-step framework, we included 228 recommendations, linked to 103 guideline questions and organized the recommendation map according to key components of the health question, including the original recommendations and rationale (https://who.tuberculosis.recmap.org/). The recommendation mapping framework provides the entire continuum of evidence mapping by framing recommendations within a guideline questions' population, interventions, and comparators domains. Recommendation maps should allow guideline developers to organize their work meaningfully, standardize the automated publication of guidelines through links to the GRADEpro guideline development tool, and increase their accessibility and usability.

Identifiants

pubmed: 33762142
pii: S0895-4356(21)00046-9
doi: 10.1016/j.jclinepi.2021.02.009
pmc: PMC8168829
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-149

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

BMJ. 2016 Jun 28;353:i2016
pubmed: 27353417
CMAJ. 2014 Feb 18;186(3):E123-42
pubmed: 24344144
CMAJ. 2010 Dec 14;182(18):E839-42
pubmed: 20603348
CMAJ. 2010 Jul 13;182(10):1045-52
pubmed: 20513780
Implement Sci. 2013 Jan 09;8:6
pubmed: 23302501
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Ann Intern Med. 2012 Aug 7;157(3):207-10
pubmed: 22868839
J Clin Epidemiol. 2017 Jan;81:101-110
pubmed: 27713072
J Clin Epidemiol. 2011 Apr;64(4):395-400
pubmed: 21194891
Altern Ther Health Med. 2003 Jul-Aug;9(4):22-30
pubmed: 12868249
CMAJ. 2003 Sep 30;169(7):677-80
pubmed: 14517128
CMAJ. 2010 Jul 13;182(10):E472-8
pubmed: 20513779
AMIA Annu Symp Proc. 2017 Feb 10;2016:1189-1198
pubmed: 28269916
Syst Rev. 2016 Feb 10;5:28
pubmed: 26864942
Res Synth Methods. 2013 Mar;4(1):49-62
pubmed: 26053539
J Am Med Inform Assoc. 2000 Sep-Oct;7(5):488-98
pubmed: 10984468
J Clin Epidemiol. 2017 Nov;91:47-53
pubmed: 28911999
JMIR Med Inform. 2019 Jan 16;7(1):e11487
pubmed: 30664458
J Am Med Inform Assoc. 2011 Dec;18 Suppl 1:i132-9
pubmed: 22052898
Int J Med Inform. 2008 Dec;77(12):787-808
pubmed: 18639485
J Clin Epidemiol. 2016 Aug;76:89-98
pubmed: 26931285
Stud Health Technol Inform. 2015;216:980
pubmed: 26262282
J Clin Epidemiol. 2013 Jul;66(7):726-35
pubmed: 23570745
Health Res Policy Syst. 2018 May 29;16(1):45
pubmed: 29843743
J Am Med Inform Assoc. 2004 Sep-Oct;11(5):418-26
pubmed: 15187061

Auteurs

Anisa Hajizadeh (A)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada.

Tamara Lotfi (T)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada.

Dennis Falzon (D)

Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland.

Dominik Mertz (D)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada; Department of Medicine, McMaster University, Hamilton (ON), Canada.

Robby Nieuwlaat (R)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada.

Nebiat Gebreselassie (N)

Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland.

Ernesto Jaramillo (E)

Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland.

Alexei Korobitsyn (A)

Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland.

Matteo Zignol (M)

Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland.

Fuad Mirzayev (F)

Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland.

Nazir Ismail (N)

Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland.

Jan Brozek (J)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada; Department of Medicine, McMaster University, Hamilton (ON), Canada.

Mark Loeb (M)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada; Department of Medicine, McMaster University, Hamilton (ON), Canada.

Thomas Piggott (T)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada.

Andrea Darzi (A)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada.

Qi Wang (Q)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada.

Al Subhi Mahmood (AS)

Department of Medicine, McMaster University, Hamilton (ON), Canada.

Praveen Saroey (P)

Department of Medicine, McMaster University, Hamilton (ON), Canada.

Micayla Matthews (M)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada.

Finn Schünemann (F)

University of Freiburg, Breisgau, Germany, Institut für Evidence in Medicine, Medical Center & Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Bart Dietl (B)

Evidence Prime Inc, Toruńska 5, 30-056 Kraków, Poland.

Artur Nowak (A)

Evidence Prime Inc, Toruńska 5, 30-056 Kraków, Poland.

Kuba Kulesza (K)

Evidence Prime Inc, Toruńska 5, 30-056 Kraków, Poland.

Giovanna E U Muti-Schünemann (GEU)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada.

Antonio Bognanni (A)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada.

Rana Charide (R)

American University of Beirut, American University of Beirut, Bliss Street, PO Box: 11-0236, Riad El Solh, Beirut 1107 2020, Lebanon.

Elie A Akl (EA)

American University of Beirut, American University of Beirut, Bliss Street, PO Box: 11-0236, Riad El Solh, Beirut 1107 2020, Lebanon.

Tereza Kasaeva (T)

Global TB Programme World Health Organization, Geneva, Switzerland, World Health Organization HQ, Avenue Appia 20, 1211 Geneva, Switzerland.

Holger J Schünemann (HJ)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON), Canada; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, Hamilton (ON), Canada; Department of Medicine, McMaster University, Hamilton (ON), Canada. Electronic address: schuneh@mcmaster.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH